CNS Pharmaceuticals Inc (CNSP)
0.216
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
0.219
0.00 (0.00%)
After-Hours: 20:00
CNS Pharmaceuticals Total Assets (Quarterly): 1.661M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.661M |
December 31, 2023 | 1.701M |
September 30, 2023 | 2.328M |
June 30, 2023 | 6.452M |
March 31, 2023 | 7.415M |
December 31, 2022 | 13.05M |
September 30, 2022 | 9.638M |
June 30, 2022 | 12.45M |
March 31, 2022 | 15.87M |
December 31, 2021 | 8.757M |
September 30, 2021 | 11.51M |
Date | Value |
---|---|
June 30, 2021 | 14.24M |
March 31, 2021 | 13.14M |
December 31, 2020 | 15.85M |
September 30, 2020 | 2.985M |
June 30, 2020 | 3.986M |
March 31, 2020 | 6.211M |
December 31, 2019 | 7.912M |
September 30, 2019 | 1.398M |
June 30, 2019 | 1.642M |
December 31, 2018 | 0.6833M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.398M
Minimum
Sep 2019
15.87M
Maximum
Mar 2022
7.910M
Average
7.663M
Median
Total Assets (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.357M |
Palatin Technologies Inc | 11.41M |
iBio Inc | 50.15M |
Theriva Biologics Inc | 48.73M |
Oragenics Inc | 3.534M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 6.091M |
Shareholders Equity (Quarterly) | -4.430M |